Purpose of Technology
Continuous glucose monitoring (CGM) systems are minimally invasive or noninvasive devices that measure glucose levels in interstitial fluid at frequent intervals over a period of several days. CGM systems are designed to obtain information regarding daily patterns in glucose levels that, when evaluated in real time or reviewed retrospectively by a physician, can guide adjustments to therapy, with the goal of improving overall glycemic control. The glucose measurements provided during continuous monitoring are not intended to replace standard self-monitoring of blood glucose (SMBG) obtained using fingerstick blood samples, but can alert the patient to the need to perform SMBG.
Relevant Questions
Does the information obtained from CGM systems used in conjunction with SMBG improve short-term glycemic outcomes and long-term health outcomes in adults with type 1 or type 2 diabetes?
Does the information obtained from CGM systems used in conjunction with SMBG improve short-term glycemic outcomes and long-term health outcomes in pediatric and adolescent patients with type 1 or type 2 diabetes?
Does the information obtained from CGM systems used in conjunction with SMBG improve short-term glycemic outcomes, pregnancy outcomes, and long-term health outcomes in pregnant women with type 1, type 2, or gestational diabetes, and in their children?
Are CGM systems safe?
Have definitive patient selection criteria been established for CGM systems?
If you have a Hayes login, click here to view the full report on the Knowledge Center.